[go: up one dir, main page]

MXPA02010028A - Hipotensores. - Google Patents

Hipotensores.

Info

Publication number
MXPA02010028A
MXPA02010028A MXPA02010028A MXPA02010028A MXPA02010028A MX PA02010028 A MXPA02010028 A MX PA02010028A MX PA02010028 A MXPA02010028 A MX PA02010028A MX PA02010028 A MXPA02010028 A MX PA02010028A MX PA02010028 A MXPA02010028 A MX PA02010028A
Authority
MX
Mexico
Prior art keywords
prorenin
activation
controlling
protein
substance
Prior art date
Application number
MXPA02010028A
Other languages
English (en)
Inventor
Kazuo Murakami
Original Assignee
Ishida Yuichi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishida Yuichi filed Critical Ishida Yuichi
Publication of MXPA02010028A publication Critical patent/MXPA02010028A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6486—Renin (3.4.23.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/23—Aspartic endopeptidases (3.4.23)
    • C12Y304/23015—Renin (3.4.23.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se provee un metodo para seleccion de una sustancia que es capaz de controlar la activacion de prorrenina, en donde se usa como indicador la capacidad de ajuste de activacion de prorrenina mediante interaccion proteina-proteina en una region de profragmento de prorrenina; una sustancia controladora de activacion de prorrenina que tiene una funcion de controlar la activacion de prorrenina basada en la interaccion proteina- proteina por medio de una region de profragmento de prorrenina; y un hipotensor, supresor de hipertrofia de organo y supresor de engrosamiento arterial que contiene dicha sustancia controladora de activacion de prorrenina como un ingrediente efectivo.
MXPA02010028A 2000-04-10 2001-04-09 Hipotensores. MXPA02010028A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000108670 2000-04-10
PCT/JP2001/003034 WO2001077673A1 (fr) 2000-04-10 2001-04-09 Hypotenseurs

Publications (1)

Publication Number Publication Date
MXPA02010028A true MXPA02010028A (es) 2004-08-19

Family

ID=18621470

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010028A MXPA02010028A (es) 2000-04-10 2001-04-09 Hipotensores.

Country Status (9)

Country Link
US (2) US6900020B2 (es)
EP (1) EP1273914A4 (es)
KR (1) KR100775980B1 (es)
CN (1) CN1311238C (es)
AU (2) AU4686401A (es)
CA (1) CA2404644A1 (es)
EA (1) EA005310B1 (es)
MX (1) MXPA02010028A (es)
WO (1) WO2001077673A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073740A1 (ja) * 2003-02-20 2004-09-02 Yuichi Ishida 組織内アンジオテンシンⅱ産生亢進制御剤並びに動脈硬化症、心・脳血管疾患及び／若しくは糖尿病合併症の発症予防又は治療剤
JPWO2006132245A1 (ja) * 2005-06-06 2009-01-08 株式会社プロテイン・エクスプレス 腫瘍増殖抑制剤
CA2983133A1 (en) * 2009-02-04 2010-08-12 Molecular Innovations Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin, and antibodies used therein
WO2014047194A1 (en) * 2012-09-19 2014-03-27 Feng Yumei Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes
US9573976B2 (en) * 2012-09-19 2017-02-21 University Of Utah Research Foundation Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes
US10780143B2 (en) 2012-09-19 2020-09-22 University Of Utah Research Foundation Compositions and methods of use for (pro)renin receptor antagonists
US9586995B2 (en) 2012-09-19 2017-03-07 University Of Utah Research Foundation Compositions and methods of use for (pro)renin receptor
JP6836748B2 (ja) * 2016-10-21 2021-03-03 富士レビオ株式会社 レニン濃度の免疫学的測定法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939747A1 (de) * 1989-06-09 1990-12-13 Bayer Ag Renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0410278B1 (de) * 1989-07-25 1994-01-19 Hoechst Aktiengesellschaft Renin-hemmende Aminooligohydroxy-Derivate
TW209870B (es) * 1990-01-18 1993-07-21 Pfizer
JP3271157B2 (ja) 1997-04-07 2002-04-02 常盤化学工業株式会社 新規な抗体、それを含むレニン活性物質及びそれを用いたプロレニン測定試薬
HU0900792D0 (en) * 1997-10-17 2010-03-01 Ark Therapeutics Ltd Use of renin-angiotensin inhibitors
JP3271159B2 (ja) * 1998-10-13 2002-04-02 常盤化学工業株式会社 レニン活性物質

Also Published As

Publication number Publication date
US7361637B2 (en) 2008-04-22
CA2404644A1 (en) 2001-10-18
CN1436305A (zh) 2003-08-13
US20030165999A1 (en) 2003-09-04
AU4686401A (en) 2001-10-23
EA200201072A1 (ru) 2003-06-26
US6900020B2 (en) 2005-05-31
KR100775980B1 (ko) 2007-11-16
WO2001077673A1 (fr) 2001-10-18
KR20020097217A (ko) 2002-12-31
US20050203021A1 (en) 2005-09-15
EP1273914A1 (en) 2003-01-08
CN1311238C (zh) 2007-04-18
EP1273914A4 (en) 2004-08-25
AU2001246864B2 (en) 2006-07-27
EA005310B1 (ru) 2004-12-30

Similar Documents

Publication Publication Date Title
BR0317715A (pt) Composições e processos de uso de collajolie
BR0215405A (pt) Composições e processos de uso de collajolie
DK1427440T3 (da) Anvendelse af plasminogen til at fremme helingen af trommehindeperforation
NO20030374L (no) Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter
DE60122718D1 (de) Strukturen und zusammensetzungen zur erhöhung der stabilität von aktiven peroxiden
ECSP066662A (es) Preparación farmacéutica que comprende un anticuerpo contra el receptor egf
DE69915617D1 (de) Langsame freisetzung von riechstoffverbindungen in parfümen unter anwendung von 2-benzoylbenzoaten,2-alkanoylbenzoaten oder alpha-ketoestern
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
ES2105398T3 (es) Grapa hemostatica quirurgica.
NO20035848L (no) Nye vevsfaktorrettede antistoffer som antikoagulanter
HN2001000217A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
ES2105493T3 (es) Catalizador para oxido de etileno, procedimiento para su produccion y uso.
BR0113798A (pt) Derivados de resorcinol
PA8521801A1 (es) Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra
ES2176961T3 (es) Mezclas solidas a base de sulfonilureas y adyuvantes.
EA200500898A1 (ru) Способ получения оптически чистых активных соединений
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
MXPA02010028A (es) Hipotensores.
AR037565A1 (es) Formas de sales de amlodipina y procedimientos para prepararlas.
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
ES2159271A1 (es) Metodo para la preparacion de 5-ciano-1-(4-fluorofenil)-1,3-dihidroisobenzofuranos
AR042652A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
DE60019117D1 (de) Substituierte benzamide als inhibitoren von rhinovirus 3c protease
BR0311699A (pt) Processo para a decomposição de hidroperóxido de cicloexila